A Phase Ib Study of Varlitinib in Japanese Subjects With Advanced or Metastatic Solid Tumours
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 12 Jan 2018
At a glance
- Drugs Varlitinib (Primary) ; Capecitabine
- Indications Biliary cancer; Solid tumours
- Focus Adverse reactions
- Sponsors ASLAN Pharmaceuticals
- 08 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 08 Mar 2017 New trial record
- 13 Feb 2017 According to an ASLAN Pharmaceuticals media release, the first patient has been enrolled in this trial.